ESC 365 - Blood plasma metabolites and heart failure risk: insights from Mendelian randomization analysis

ESC Professional Premium Access

Blood plasma metabolites and heart failure risk: insights from Mendelian randomization analysis

Session: Markers for the severity of worsening heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor Z. Ma (Heidelberg, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Ziqi Ma

Heidelberg (Germany)

0 follower

4 more presentations in this session

Comparing de novo heart failure and acute decompensated heart failure using a proteomic approach

Speaker: Mrs A. Dieden (Malmoe, SE)

Prognostic impact of systemic immune-inflammation index in patients with acute decompensated heart failure with preserved ejection fraction -PURSUIT-HFpEF Registry-

Speaker: Mr Y. Kokubu (Osaka, JP)

VExUS score improvement is associated with better outcomes in acute decompensated heart failure

Speaker: Doctor M. Saadi (Porto Alegre, BR)

Serial shock severity assessment within seventy-two hours after diagnosis: a cardiogenic shock working group report

Speaker: Doctor V. Ton (Boston, US)

Access the full session

Markers for the severity of worsening heart failure

Speakers: Doctor Z. Ma, Mrs A. Dieden, Mr Y. Kokubu, Doctor M. Saadi, Doctor V. Ton

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources